Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: an in vitro model for assessment

scientific article published in February 1998

Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: an in vitro model for assessment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0022-5347(01)63949-1
P698PubMed publication ID9649264

P50authorJudah FolkmanQ710619
P2093author name stringRiedmiller H
Richie JP
Stewart R
Weingärtner K
Ben-Sasson SA
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectprostatic hypertrophyQ506659
P304page(s)465-470
P577publication date1998-02-01
P1433published inJournal of UrologyQ15709979
P1476titleEndothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: an in vitro model for assessment
P478volume159

Reverse relations

cites work (P2860)
Q33598141Angiogenesis in urological malignancy: prognostic indicator and therapeutic target
Q30991940Do urinary levels of vascular endothelial growth factor predict proliferative retinopathy?
Q80709524Effect of chronic prostatitis on angiogenic activity and serum prostate specific antigen level in benign prostatic hyperplasia
Q40613199Pancreatic cancer growth is inhibited by blockade of VEGF-RII.
Q41988384RETRACTED: Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia
Q33955367The role of angiogenesis in prostate and other urologic cancers: a review
Q77359737Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate
Q73179856Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer

Search more.